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Atrial fibrillation, the most common sustained cardiac arrhythmia, has a complex and 
multifaceted pathophysiology1. The presence of a predisposing substrate, frequently  
encompassing atrial hypertrophy, fibrosis and significant alterations of the extracellular 
matrix, is contributing to intra-atrial electrical conduction delay as well as shortening and 
dispersion of atrial refractory periods. Triggers like short-coupled supraventricular 
extrasystoles can initiate the arrhythmia acting on this pathological milieu with the potential 
contribution of modulating factors such as the autonomic nervous system, ischemia and 
hormones.  
The initial clinical experiences of transcatheter ablation of atrial fibrillation were reported 
twenty years ago almost simultaneously by different groups2,3. Mimicking atrial debulking 
and compartmentalization provided by surgical techniques such as the classical Maze 
procedure, these transcatheter approaches aimed at substantial atrial substrate 
modification. A few years later, the recognition by Haissaguerre and colleagues that most of 
the ectopic foci initiating atrial fibrillation were located in the pulmonary veins4,  shifted the 
attention of the Electrophysiological community from substrate to triggers of the 
arrhythmia. The observation that ablation with local radiofrequency energy of the ectopic 
foci achieved 62% freedom from atrial fibrillation, paved the way for circumferential 
pulmonary vein isolation widespread use which soon became the cornerstone of paroxysmal 
atrial fibrillation interventional treatment showing higher efficacy as compared with 
antiarrhythmic drugs5. However, in patients presenting with persistent atrial fibrillation, 
pulmonary vein isolation proved to be insufficient if used as stand-alone ablation strategy 
showing only modest long-term success rates6,7. These findings suggested the existence of a 
more complex electrophysiological substrate in patients with persistent atrial fibrillation 
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with structures and mechanisms involved in facilitation and maintenance of the arrhythmia 
residing outside the pulmonary veins8. As a consequence, efforts were redirected towards 
atrial fibrillation substrate modification with several non-pulmonary veins targets used as 
guidance for transcatheter ablation. Linear ablation between fixed anatomical structures 
(e.g. left atrial roof and/or mitral isthmus) provided additional benefit to circumferential 
pulmonary vein isolation in patients with persistent atrial fibrillation9,10. Subsequently, 
mapping and ablation of complex fractionated atrial electrograms defined as either 
continuous re-entry of the fibrillation waves into the same area or overlap of different 
wavelets entering the same area at different times, was proposed by Nademanee and 
colleagues as a new ablative approach aiming at atrial fibrillation substrate modification11. 
Other groups studied the role of  autonomic nervous system in atrial fibrillation 
pathophysiology investigating the curative effects of partial vagal denervation secondary to 
atrial ganglia transcatheter ablation12,13. 
In clinical practice, different combinations of these ablative approaches  have been tested 
for the treatment of persistent atrial fibrillation. One of the most commonly used is the so-
called “stepwise” approach encompassing pulmonary vein isolation followed by ablation of 
complex fractionated electrograms and linear lines aiming at atrial fibrillation cycle length 
slowing and, possibly, arrhythmia termination by conversion either directly to sinus rhythm 
or to an atrial tachycardia which is then mapped conventionally and ablated14. Although the 
stepwise approach confers acceptable long-term freedom from arrhythmia recurrence, 
success rates with a single procedure remain limited with the necessity of multiple 
procedures in most of the cases15. Inevitably, this approach is associated with longer 
procedural times, patients exposure to higher radiation doses and, potentially, to an 
increased risk of complications. In addition, extensive ablation scheme determining 
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substrate modification, can often result in significant impairment of left atrial function and 
occurrence of post-procedural atrial tachycardias16,17.  
In the attempt to contribute to the challenging quest for the optimal ablation strategy in 
patients with persistent atrial fibrillation, Yang and colleagues in this issue of Circulation: 
Arrhythmia and Electrophysiology, describe a voltage-based approach for atrial substrate 
modification in patients with persistent or long-standing persistent atrial fibrillation 
undergoing transcatheter ablation18. Following pulmonary vein isolation plus cavotricuspid 
isthmus ablation, patients cardiovertable to sinus rhythm, underwent high density bipolar 
mapping of the left atrium to identify low voltage zones (defined as bipolar voltage range 
between 0.1 and 0.4 mV) and sites with abnormal electrograms  suggestive of local 
conduction delay in what the authors call transitional zones (defined as bipolar voltage range 
between 0.4 to 1.3 mV). Abnormal electrograms were defined as multiphasic signals with ≥3 
positive or negative distinct peaks with duration ≥50 ms. The subsequent substrate 
modification strategy consisted in ablation of low voltage zones to achieve “electrical 
silence” (bipolar electrogram <0.1 mV) and elimination of abnormal electrograms identified 
in the transitional zone. In addition, short linear lesions were performed between isolation 
lines or anatomical barriers and low voltage zones to eliminate channels for potential re-
entrant activity. This ablation strategy was compared with a classic stepwise approach  in an 
age- and sex-matched historical control group undergoing non paroxysmal atrial fibrillation 
transcatheter ablation in the same center two years earlier. In the study group, amongst 
patients successfully cardioverted to sinus rhythm, 70% showed low voltage zones or 
abnormal electrograms mainly in the anterior and posterior left atrial walls and in the atrial 
roof. Over a median follow-up of 30 months, freedom from arrhythmic recurrences was 66% 
in the study group compared with 37% in the control group. Of note, atrial fibrillation 
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recurrence was similar in the two groups (30% vs. 32%) whereas atrial tachycardia incidence 
was significantly lower in the study group (3.5% vs. 30%). These results were achieved  with 
shorter procedural and fluoroscopy times and with lower complications rates in the study 
group as compared with the control group.  The authors performed also a small mechanistic 
study presented in the same manuscript: in 15 patients with persistent atrial fibrillation, 
following pulmonary vein isolation, complex fractionated atrial electrograms mapping as 
well as sinus rhythm voltage mapping were performed demonstrating a co-localization of 
low voltage/transitional zones  and slow conduction and/or rotational activation during 
atrial fibrillation/tachycardia.   
The use of sinus rhythm voltage mapping as a tool to guide atrial fibrillation substrate 
modification was first described by the Leipzig group19. Partially echoing this approach, the 
strategy proposed by Yang and colleagues, targeting potentially proarrhythmic regions of 
atrial fibrosis based on electrophysiological findings, proved to be feasible and effective in a 
similar population with non-paroxysmal atrial fibrillation (i.e. persistent or long-standing 
persistent atrial fibrillation) with relatively short duration of the arrhythmia (median atrial 
fibrillation duration 15 months). The rationale for this approach was already investigated 
and reported by the same group in a previous study showing a parallel progression between 
atrial fibrosis and electrophysiological abnormalities in patients with atrial fibrillation20. Such 
“substrate based” ablation approach resembles what has been done during the last ten 
years for ventricular tachycardia in which mapping during sinus rhythm has been successfully 
used to identify abnormal myocardial substrate amenable to  ablation.  The authors should 
be congratulated for their contribution which adds a small piece to the puzzle of the 
complex mechanisms and pathophysiology of persistent atrial fibrillation. However, a few 
limitations should be considered in interpreting the results of this study, namely the non-
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randomized design with all the inherent limitations and bias, the single center setup with a 
significant time frame considered potentially favoring the innovative ablative strategy as 
compared with the “historical” stepwise approach. Also, it should be taken into account that 
patients successfully cardioverted to sinus rhythm after pulmonary vein isolation were 
probably a subset of subjects with less advanced left atrium structural and electrical 
remodeling as compared with patients who needed a stepwise approach, potentially 
explaining the worst outcomes observed in the latter. In order to overcome these 
limitations, the same group of investigators has designed a multicenter randomized clinical 
trial (STABLE-SR, clinicaltrials.gov number NCT01761188) which hopefully will provide 
additional information regarding this topic.  
This notwithstanding, several unanswered questions remains regarding persistent atrial 
fibrillation optimal ablation strategy. First, long-term durability of electrophysiologically 
guided substrate modification has not been investigated so far. Second, the feasibility and 
usefulness of real time integration between delayed-enhancement left atrium magnetic 
resonance imaging (effectively localizing and quantifying fibrosis) and high-density voltage 
mapping information will have to be tested in human. Third, it is still unclear whether 
pulmonary vein isolation per se is playing a role in atrial substrate modification and 
homogenization. In fact, large antral isolation areas may coincidentally eliminate fibrotic 
regions determining conduction block and intra-atrial reentry sustaining persistent atrial 
fibrillation. Fourth, besides the left atrium, other anatomical structures like the coronary 
sinus, the left atrial appendage and the right atrium (including superior vena cava) are 
involved in atrial fibrillation initiation and maintenance. Therefore, an electrophysiologically 
guided substrate modification involving such structures should be implemented in the 
future. Finally, it will be interesting to test the impact of new available technologies such as 
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contact force-sensing and multipolar catheters on high-density mapping resolution and 
clinical outcome. 
In conclusion, modification of non-paroxysmal atrial fibrillation substrate during sinus 
rhythm as proposed by Yang and colleagues is a new approach allowing personalization of 
the ablation scheme according to individual characteristics and providing good results with a 
low risk of iatrogenic atrial tachyarrhythmias. If these promising results will be replicated in 
the setting of properly designed prospective multicenter randomized clinical trials, a 
significant step forward  in atrial fibrillation treatment will be made. 
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